How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
|Articles|June 1, 2002
- Volume 0 0
SNAKE OIL
Advertisement
?There is as yet no convincing evidence that administration of any specific compound, natural or artificial, can globally slow aging in people, or even in mice or rats.? The pronouncement comes from a panel created by the International Longevity Center (ILC)-USA, a not-for-profit, nonpartisan research organization, an affiliate of Mt. Sinai School of Medicine, New York, NY.
The full report, ?Is There an Anti-Aging Medicine?? can be downloaded from the ILC-USA web site at
Articles in this issue
over 24 years ago
Rofecoxib (Vioxx)over 24 years ago
Prescription Drug Abuse Trends, Part II: Class 4over 24 years ago
Osteoporosis: Understanding Bisphosphonate Therapyover 24 years ago
Oral Contraceptivesover 24 years ago
Hospital Rounds: Focus on Allergyover 24 years ago
Happy 60th Birthday, Premarin!over 24 years ago
St.-Johns'-Wort Is Ineffective for Major Depressionover 24 years ago
Mild Depression Linked to Poor Dietover 24 years ago
Healthful Power of SpirituralityAdvertisement
Related to this article
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Advertisement
Advertisement
Trending on Pharmacy Times
1
AHA 2026: Pharmacists at the Center of Cardiometabolic Care
2
From Recognition to Prior Authorization: ATTR-CM Diagnosis Gaps
3
FDA Approves Perioperative Durvalumab Plus Enfortumab Vedotin-ejfv for MIBC
4
Glucose Monitoring: Timing Makes Every Reading Count
5